In addition, the overexpression of HLA-J after neoadjuvant chemotherapy has been reported to be associated with reduced survival rates in breast cancer [27], which suggests altered immune evasion caused by HLA-J rs767861647 mutation might be involved in breast cancer progression. This evidence concerns the gene HLA-J and breast cancer.